BEVACIZUMAB

Basic Information

Item Value
DrugBank ID DB00112
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 20

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 malignant epithelial tumor of ovary TxGNN Knowledge Graph
2 primary peritoneal serous/papillary carcinoma TxGNN Knowledge Graph
3 fallopian tube carcinoma TxGNN Knowledge Graph
4 glioblastoma (disease) TxGNN Knowledge Graph
5 undifferentiated carcinoma of the corpus uteri TxGNN Knowledge Graph
6 desmoplastic small round cell tumor TxGNN Knowledge Graph
7 glioma susceptibility TxGNN Knowledge Graph
8 peritoneum cancer TxGNN Knowledge Graph
9 fallopian tube cancer TxGNN Knowledge Graph
10 primary malignant peritoneal tumor TxGNN Knowledge Graph
11 cervical carcinoma TxGNN Knowledge Graph
12 squamous cell carcinoma of the corpus uteri TxGNN Knowledge Graph
13 breast cancer TxGNN Knowledge Graph
14 hereditary breast ovarian cancer syndrome TxGNN Knowledge Graph
15 cervical cancer TxGNN Knowledge Graph
16 breast neoplasm TxGNN Knowledge Graph
17 cervical adenocarcinoma TxGNN Knowledge Graph
18 primary peritoneal carcinoma (disease) TxGNN Knowledge Graph
19 hereditary breast carcinoma TxGNN Knowledge Graph
20 metastatic malignant neoplasm in the colon TxGNN Knowledge Graph

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search